PUBLIC HEALTH ALERT on LIMBREL: The FDA continues to receive and investigate reports of serious adverse events related to Limbrel and urges consumers who are taking this product to stop immediately. The agency has recommended that Primus Pharmaceuticals recall Limbrel. Read more about this investigation at: https://www.fda.gov/Food/RecallsOutbreaksEmergencies/SafetyAlertsAdvisories/ucm585992.htm




Source